Loading the section
Prices delayed by 15 minutes
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Haemonetics Corporation trades on NYSE under the ticker HAE. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks HAE has traded between 48.17 $ and 110.45 $. As of 09 October 2026 the price stood 85.97 % of the way from the 52-week low to the high.
Over one year HAE shares rose 105.27 %; over six months they rose 70.86 %. Volatility over 90 days is 38.97 %. Dividends are not included: this is price change only, as of 09 October 2026.
HAE trades at a price-to-earnings ratio of 31.8, above the sector median of 24.8. Price to sales is 4.2, above the sector median of 3.9. Price to book is 6.1, above the sector median of 2.4. Calculated from reports for the period ending 31 December 2025.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 119.81 | 121.19 | 116.52 | 118.69 | 1M |
| 08 October 2026 | 115.00 | 121.00 | 111.66 | 119.47 | 3M |
| 07 October 2026 | 103.48 | 104.02 | 101.32 | 101.71 | 625,600 |
| 06 October 2026 | 104.92 | 105.58 |
Based on the last 12 months of reports, through 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Haemonetics Corporation (HAE) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-03-31, revenue was 1.4bn $, net income was 167.7m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:125 SUMMER STREET, BOSTON, MA, 02110, US
Haemonetics Corporation reported revenue of 1.3B $ and net income of 175M $ over the last four quarters. Net margin is 13.31 %. Revenue changed by −4.02 % year over year. Earnings per share are 3.63 $. Market capitalisation is 5.6B $.
HAE has a return on equity of 19.25 %, above the sector median of −41.68 %. Return on assets is 7.04 %, above the sector median of −32.11 %. Operating margin is 19.05 %, above the sector median of −26.84 %.
| 326M |
| DXCMDexCom, Inc. | 84.15 | −0.31 % | 324M |
| MDLNMedline Inc. | 36.33 | +1.64 % | 297M |
| RMDResMed Inc. | 230.43 | +1.63 % | 283M |
| PODDInsulet Corporation | 134.61 | +0.10 % | 247M |
| 102.80 |
| 103.52 |
| 542,000 |
| 05 October 2026 | 104.29 | 106.26 | 103.65 | 104.68 | 652,600 |
| 02 October 2026 | 104.58 | 105.70 | 103.61 | 104.68 | 328,600 |
| 01 October 2026 | 105.71 | 106.67 | 103.51 | 104.37 | 454,300 |
| 30 September 2026 | 105.42 | 105.78 | 103.54 | 105.30 | 508,900 |
| 29 September 2026 | 104.99 | 106.52 | 104.60 | 105.80 | 451,200 |
| 28 September 2026 | 105.14 | 106.22 | 104.44 | 105.79 | 472,100 |
| 25 September 2026 | 105.72 | 106.58 | 104.71 | 105.30 | 492,600 |
| 24 September 2026 | 106.67 | 108.22 | 105.92 | 106.00 | 416,800 |
| 23 September 2026 | 108.56 | 110.28 | 106.70 | 106.82 | 704,900 |
| 22 September 2026 | 109.26 | 110.14 | 108.38 | 108.52 | 446,600 |
| 21 September 2026 | 109.24 | 110.06 | 108.05 | 108.73 | 327,000 |
| 18 September 2026 | 108.95 | 110.45 | 107.60 | 108.40 | 1M |
| 17 September 2026 | 108.39 | 109.83 | 107.56 | 107.60 | 621,100 |
| 16 September 2026 | 105.90 | 106.78 | 104.78 | 106.24 | 520,700 |
| 15 September 2026 | 105.14 | 106.87 | 103.24 | 106.20 | 440,000 |
| 14 September 2026 | 106.98 | 107.47 | 102.84 | 106.31 | 887,900 |